Resource Center
CMV-specific Immunity Assessment: Studies Including CMV inSIGHT™ Testing
Join us for an insightful presentation with real-world data and patient case studies utilizing the CMV inSIGHT™ T Cell Immunity test. Identify how you can utilize this cell mediated immunity assay in your immunocompromised patients to evaluate their immune response to CMV. These answers can assist in personalizing your approach to your patients CMV antiviral therapy.
Featured Resource
Immunity Testing: CMV in Lung Transplant Patients
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.
Search the Eurofins Viracor online test directory
for the most up-to-date assay offerings and information
Test Menu